ANTHONY MAIDA

Insider Reports History

Location
Irvine, CA
Signature
/s/ Anthony Maida
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ANTHONY MAIDA:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oncotelic Therapeutics, Inc. Chief Clin. Ops. Officer, Director Common Stock 1.14M $29.6K $0.03 31 Mar 2021 Direct
Oncotelic Therapeutics, Inc. Chief Clin. Ops. Officer, Director Stock Options 600K 03 Sep 2021 Direct
Oncotelic Therapeutics, Inc. Chief Clin. Ops. Officer, Director Series A Convertible Preferred Stock 0 31 Mar 2021 Direct

Insider Reports Filed by ANTHONY MAIDA

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OTLC Oncotelic Therapeutics, Inc. 03 Sep 2021 1 $0 4 Chief Clin. Ops. Officer, Director 08 Sep 2021, 17:00
OTLC Oncotelic Therapeutics, Inc. 31 Mar 2021 3 $0 4 CHIEF CLINICAL OFFICER, Director 16 Jul 2021, 17:39